These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34089097)

  • 21. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.
    Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F
    Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative bioavailability of nicotine from a nasal spray in infectious rhinitis and after use of a topical decongestant.
    Lunell E; Molander L; Andersson M
    Eur J Clin Pharmacol; 1995; 48(1):71-5. PubMed ID: 7542589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xylometazoline hydrochloride 0.1 per cent versus physiological saline in nasal surgical aftercare: a randomised, single-blinded, comparative clinical trial.
    Humphreys MR; Grant D; McKean SA; Eng CY; Townend J; Evans AS
    J Laryngol Otol; 2009 Jan; 123(1):85-90. PubMed ID: 18405405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis.
    Graf C; Bernkop-Schnürch A; Egyed A; Koller C; Prieschl-Grassauer E; Morokutti-Kurz M
    Int J Gen Med; 2018; 11():275-283. PubMed ID: 30013382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold.
    Strandell B; Norgren-Holst E; Tran N; Jakobsen HB; Chen S
    Int J Clin Pharmacol Ther; 2009 Dec; 47(12):744-51. PubMed ID: 19954713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Decongestant nasal spray. Results of a rhinomanometric double-blind study].
    Maranta CA; Simmen D
    Schweiz Med Wochenschr; 1996 Nov; 126(44):1875-80. PubMed ID: 8984600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical review of 33 cases of rhinitis medicamentosa by decongestant nasal spray].
    Yuta A; Ogawa Y
    Arerugi; 2013 Dec; 62(12):1623-30. PubMed ID: 24608651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment.
    Kar M; Ince I; Yildirim C; Burukoğlu Dönmez D; Karasulu Y; Cingi C
    Eur Rev Med Pharmacol Sci; 2022 Dec; 26(2 Suppl):65-71. PubMed ID: 36524913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical glucocorticoid reduces the topical decongestant-induced histologic changes in an animal model nasal mucosa.
    Akpinar ME; Yigit O; Akakin D; Sarioz O; Ozkan N; Yildiz SD; Azizli E; Sehirli US
    Laryngoscope; 2012 Apr; 122(4):741-6. PubMed ID: 22374848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histomorphological Study of a New Nasal Spray with Anti-inflammatory Properties Efficacy in Rabbits with Rhinosinusitis.
    Zupanets I; Zhulai T; Shebeko S; Otrishko I; Hladkykh D
    Med Arch; 2020 Feb; 74(1):8-13. PubMed ID: 32317827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.
    Mortuaire G; de Gabory L; François M; Massé G; Bloch F; Brion N; Jankowski R; Serrano E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):137-44. PubMed ID: 23375990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled trial comparing a xyloglucan-based nasal spray with saline in adults with symptoms of rhinosinusitis.
    Allegrini A; Pavone D; Carluccio F
    Curr Med Res Opin; 2018 Mar; 34(3):377-385. PubMed ID: 28604115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of the efficacy of combined nasal topical drug and topical decongestants in the treatment of acute rhinosinusitis].
    Shakhova EG
    Vestn Otorinolaringol; 2020; 85(4):46-50. PubMed ID: 32885637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical nasal xylometazoline for flexible bronchoscopy (VAIN): A randomized, double-blind, placebo-controlled trial.
    Sryma PB; Mittal S; Tiwari P; Mohan A; Hadda V; Guleria R; Madan K
    Respir Investig; 2021 May; 59(3):350-355. PubMed ID: 33518471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
    Berger WE; Fineman SM; Lieberman P; Miles RM
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Contribution of Galenics to Patients' Sensory Perception of Nasal Sprays After Nasal Surgery: Data from a Prospective Randomised, Controlled, Double-Blind, Crossover, Multicentre Study.
    Bergmann C; Lander J; Radtke L; England L; Singh J; Mösges R
    Adv Ther; 2021 Dec; 38(12):5829-5843. PubMed ID: 34689304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of xylometazoline spray for expansion of nasal cavity.
    Han JS; Park SH; Shin YD; Kwon E; Shim WS; Bae JH
    Korean J Anesthesiol; 2013 Aug; 65(2):132-5. PubMed ID: 24023995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nasal toilet in infants with rhinitis: nasal passage crucial, so treat with xylometazoline].
    Mensink MHA; Wieringa N; Videler W; Klok T
    Ned Tijdschr Geneeskd; 2022 May; 166():. PubMed ID: 35736357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.